U.S. Water Utilities Stock News

Expand Energy has partnered with Evolution Well Services to deploy 100% electric hydraulic fracturing technology in Northeast Appalachia. The initiative targets lower noise, a smaller equipment footprint, reduced surface disruption, and real time environmental monitoring. The move reflects a focus on operational efficiency and environmental performance that has not featured in recent company updates. For investors watching Expand Energy (NasdaqGS:EXE), this partnership adds a fresh...

Clearway Energy (CWEN.A) just closed out FY 2025 with Q4 revenue of US$310 million and a basic EPS loss of US$0.85, capping a trailing twelve month period that totaled US$1.4 billion of revenue and US$1.42 in basic EPS. The company has seen quarterly revenue move from US$256 million in Q4 2024 to US$310 million in Q4 2025. Over the same period, basic EPS shifted from US$0.03 to a loss of US$0.85, against a backdrop of trailing twelve month net income of US$169 million. For investors, that mix...

If you are wondering whether Northern Oil and Gas is offering fair value at its current share price, or if the market is missing something, this article will walk you through what the numbers are indicating. The stock most recently closed at US$27.30, with returns of 5.2% over the past week, 16.4% over the past month, 24.0% year to date and a 12.3% decline over the past year. This raises questions about how its current price lines up with its fundamentals. Recent news coverage around...

The U.S. Supreme Court recently overturned tariffs introduced under the Trump administration, a move expected to lower import costs for parts and materials used by U.S. manufacturers, including construction-related firms like Limbach Holdings. For Limbach, whose projects rely heavily on material and equipment inputs, reduced tariff-related costs could improve project economics and enhance the competitiveness of its building systems services. We’ll now examine how potentially lower input...

The Trump administration announces a new 15% global tariff package. Tariffs apply to a wide range of imports, affecting VF Corp's international supply chain. VF Corp (NYSE:VFC), an apparel company with extensive global operations, faces new regulatory and cost uncertainties. VF Corp, the owner of multiple apparel and footwear brands, relies heavily on cross border sourcing and manufacturing. A 15% global tariff framework directly touches that setup, raising questions about input costs,...

Independence Realty Trust (IRT) has drawn attention after recent trading left the shares around $16.72, with mixed total returns over the past year and 3 years, prompting fresh investor interest in its multifamily REIT profile. See our latest analysis for Independence Realty Trust. Recent trading has been slightly positive, with a 1-day share price return of 1.64% and a 7-day share price return of 1.89%. However, the year to date share price return of 5.00% and 1-year total shareholder return...

Earlier in February 2026, Qualys reported fourth-quarter FY 2025 results showing 10% revenue growth, with international markets rising 15% and channel revenue increasing 17%, and issued 2026 guidance calling for 7% to 8% full-year growth and 8% to 9% growth for the first quarter. Management highlighted that this outlook assumes only moderate new-business contributions and no material change in net dollar expansion, underlining how much current performance depends on expanding existing...

Carter's (CRI) is back in focus after several large brokerages, including UBS and Citigroup, adjusted their views on the stock. This has drawn fresh attention to sentiment ahead of the upcoming earnings release. See our latest analysis for Carter's. The latest share price of $42.39 sits against a strong recent run, with a 30 day share price return of 18.87% and a 90 day gain of 31.32%. At the same time, the 3 year total shareholder return of 35.48% and 5 year total shareholder return of...

Wondering if Reinsurance Group of America is reasonably priced at around US$218 a share, or if the market is missing something about its value right now? The stock closed at US$218.41, with a 1.6% decline over the last 7 days, a 12.0% return over 30 days, 7.4% year to date, 11.4% over 1 year, 60.1% over 3 years, and 94.0% over 5 years. This gives investors plenty to consider in terms of risk and reward. Recent coverage has focused on Reinsurance Group of America as a key player in the life...

THOR Industries (NYSE:THO) has reorganized its North American RV operations to create two new operating groups focused on alignment and efficiency. The company announced related executive leadership changes as part of this restructuring. The move is intended to reshape how THOR coordinates its brands and manages its RV segment across North America. THOR Industries, a major manufacturer in the recreational vehicle space, sits at the center of a sector that is closely tied to consumer...

Teekay Tankers (NYSE:TNK) has moved ahead with a major fleet renewal, adding newer vessels and selling older ships. The company is acting during one of the strongest spot rate markets for crude and product tankers in more than ten years. Management is reshaping the fleet while global trade routes shift in response to sanctions and changing seaborne flows. Teekay Tankers focuses on transporting crude oil and refined products across key global shipping routes. The latest fleet moves come as...

If you are wondering whether Two Harbors Investment is trading at an appealing price today, or if the market is missing something in plain sight, this article is designed to help you answer that question using numbers rather than hype. The share price closed at US$10.56, with a 7.4% decline over the last 7 days, a 21.0% decline over 30 days, a 12.2% decline over the past year, a 0.2% decline year to date, and a 27.9% decline over five years. Recent moves in mortgage REITs and related...

In February 2026, Kimco Realty reported fourth-quarter and full-year 2025 results showing higher annual revenue and net income, completed a US$195.58 million buyback program repurchasing 11,200,000 shares, issued 2026 net income guidance of US$0.80–US$0.84 per share, and declared higher common and ongoing preferred dividends payable in March and April 2026. An interesting aspect is how the combination of rising full-year earnings, a 4.0% common dividend increase, and completion of a...

Recent coverage highlighted a past market rotation that boosted interest in high-yield dividend REITs, with Omega Healthcare Investors drawing attention for its income profile and cash flow resilience compared with growth-focused technology names. The spotlight on Omega’s above-benchmark yield, strong institutional ownership, and healthcare-focused real estate portfolio underlines its role as an income-oriented option for investors seeking stability during periods of market volatility. We’ll...

In recent days, UP Fintech Holding Ltd saw a surge in bullish options activity, with call option volumes tripling and implied volatility rising ahead of its now-released earnings report. This unusual options positioning highlights how derivatives traders are tactically using leverage to express expectations about UP Fintech’s near‑term fundamentals and potential earnings surprises. We’ll now examine how this spike in bullish options activity ahead of earnings could influence UP Fintech’s...

If you are wondering whether EVERTEC's current share price still reflects its true potential, or if the market has marked it down too far, this article is for you. With EVERTEC's share price at US$25.78 and share price returns of a 2.2% decline over 7 days, 13.5% decline over 30 days, 10.1% decline year to date, 21.4% decline over 1 year, 29.3% decline over 3 years and 28.1% decline over 5 years, many investors are asking what the stock is really worth now. Recent coverage has focused on...

Resideo Technologies (REZI) is drawing attention after recent trading left the shares at a last close of US$34.60, with a mixed return profile over the past year and over multi-year periods. See our latest analysis for Resideo Technologies. Recent trading has been choppy, with a 1-day share price return of 5.77% and a 7-day share price return of 3.43% pulling back some of the gains from a 90-day share price return of 8.77%. At the same time, the 1-year total shareholder return of 77.44% and...

What recent returns say about QMMM Holdings (QMMM) QMMM Holdings (QMMM) has attracted attention after a 19.4% one day move, a return of 19.4% over the past 3 months, and a year to date gain of 87.44%. See our latest analysis for QMMM Holdings. That surge in the 1 day share price return and the latest share price of $119.4 comes on top of a 90 day share price return of 19.4% and a very large year to date share price gain. The 1 year total shareholder return is also very large, suggesting...

Edwards Lifesciences, ticker NYSE:EW, plans to launch new left atrial appendage closure products in 2026. The products will build on the company’s existing surgical franchise to enter a growing treatment segment for atrial fibrillation patients. The move broadens Edwards Lifesciences’ portfolio beyond its core offerings in structural heart therapies. Edwards Lifesciences, trading at $82.44, is preparing to extend its reach with new left atrial appendage closure devices that sit alongside...

If you are wondering whether Helmerich & Payne at around US$35.13 is offering good value today, you are not alone. This article will walk through what the current market price might be implying. The stock has seen returns of 5.8% over the past week, 8.8% over the last 30 days, 17.3% year to date and 32.8% over the past year, while the 3 year return is a 4.0% decline and the 5 year return is 43.5%. Recent price moves sit against a backdrop of ongoing interest in energy and drilling companies,...

Why Gossamer Bio’s PROSERA readout matters now Gossamer Bio (GOSS) has drawn fresh attention after releasing topline Phase 3 PROSERA data for seralutinib in pulmonary arterial hypertension and scheduling a special call to review the results and potential next steps with regulators. See our latest analysis for Gossamer Bio. The unveiling of the PROSERA Phase 3 topline data and the planned FDA discussions come after a sharp reset in sentiment, with a 30 day share price return of 84.32% decline...

Figure Technology Solutions (FIGR) is back in focus after completing a US$150 million follow on equity offering at US$32 per Class A share, together with preliminary guidance for its fourth quarter and full year 2025 results. See our latest analysis for Figure Technology Solutions. The follow on offering and fresh guidance come after a volatile spell for Figure Technology Solutions. A 1 day share price return of 3.76% took the stock to US$30.215, while a 30 day share price return of 51.89%...

RenaissanceRe Holdings’ board previously approved a quarterly dividend increase to US$0.41 per share from US$0.40, payable on March 31, 2026 to shareholders of record on March 13, 2026, and reported completing share repurchases totaling 3,065,414 shares across two programs for a combined US$780.48 million. The company’s three-decade pattern of annual dividend increases, paired with recently completed buybacks that retired nearly one-twentieth of its share base, highlights a sustained...

Krystal Biotech received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for KB707 in advanced non small cell lung cancer. The company reported progress across its gene therapy pipeline, including pivotal ophthalmology trials with data expected next year. These updates extend Krystal Biotech’s focus beyond rare skin diseases into larger indications such as lung cancer. For investors following Krystal Biotech, ticker NasdaqGS:KRYS, the RMAT news comes with the shares at $274.59...